Patents by Inventor Heike Prinz

Heike Prinz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Transdermal Therapeutic System for Administering an Active Substance
    Publication number: 20200289426
    Abstract: The present invention relates to a transdermal therapeutic system for administering an active substance through the skin, said system being suitable for an application period of at least three days, comprising the layers arranged in the following order with respect to each other: a) a cover layer, b) an active substance layer comprising a polymer matrix containing the active substance, c) an adhesive layer comprising a contact adhesive, which consists of a mixture of one or more polyisobutylenes and one or more polybutenes, and d) a pull-off layer.
    Type: Application
    Filed: April 28, 2020
    Publication date: September 17, 2020
    Inventors: Britta LANGER, Björn SCHURAD, Heike PRINZ
  • Transdermal therapeutic system for administering an active substance
    Patent number: 10660863
    Abstract: The present invention relates to a transdermal therapeutic system for administering an active substance through the skin, said system being suitable for an application period of at least three days, comprising the layers arranged in the following order with respect to each other: a) a cover layer, b) an active substance layer comprising a polymer matrix containing the active substance, c) an adhesive layer comprising a contact adhesive, which consists of a mixture of one or more polyisobutylenes and one or more polybutenes, and d) a pull-off layer.
    Type: Grant
    Filed: December 14, 2011
    Date of Patent: May 26, 2020
    Assignee: Luye Pharma AG
    Inventors: Britta Langer, Björn Schurad, Heike Prinz
  • Transdermal therapeutic system for administering rivastigmine or derivatives thereof
    Patent number: 10076502
    Abstract: The present invention relates to a transdermal therapeutic system for administering an active substance through the skin, comprising: a) a cover layer, b) a reservoir present on the cover layer, comprising a polymer matrix comprising the active substance, c) an adhesive layer present on the reservoir comprising a contact adhesive, and d) a removable layer present on the adhesive layer, the active substance being rivastigmine, a physiologically compatible salt, hydrate, solvate or derivative thereof, characterized in that the polymer matrix of the reservoir comprises neither hydroxyl groups nor carboxyl groups.
    Type: Grant
    Filed: December 19, 2014
    Date of Patent: September 18, 2018
    Assignee: Luye Pharma AG
    Inventors: Heike Prinz, Bjorn Schurad, Thomas Beckert, Kristina Linder
  • Transdermal Therapeutic System For Administering Rivastigmine Or Derivatives Thereof
    Publication number: 20170100346
    Abstract: The present invention relates to a transdermal therapeutic system for administering an active substance through the skin, comprising: a) a cover layer, b) a reservoir present on the cover layer, comprising a polymer matrix comprising the active substance, c) an adhesive layer present on the reservoir comprising a contact adhesive, and d) a removable layer present on the adhesive layer, the active substance being rivastigmine, a physiologically compatible salt, hydrate, solvate or derivative thereof, characterized in that the polymer matrix of the reservoir comprises neither hydroxyl groups nor carboxyl groups.
    Type: Application
    Filed: December 19, 2014
    Publication date: April 13, 2017
    Inventors: Heike Prinz, Bjorn Schurad, Thomas Beckert, Kristina Linder
  • Transdermal Therapeutic System For Administering Rivastigmine Or Derivatives Thereof
    Publication number: 20150112285
    Abstract: The present invention relates to a transdermal therapeutic system for administering an active substance through the skin, comprising: a) a cover layer, b) a reservoir present on the cover layer, comprising a polymer matrix comprising the active substance, c) an adhesive layer present on the reservoir comprising a contact adhesive, and d) a removable layer present on the adhesive layer, the active substance being rivastigmine, a physiologically compatible salt, hydrate, solvate or derivative thereof, characterized in that the polymer matrix of the reservoir comprises neither hydroxyl groups nor carboxyl groups.
    Type: Application
    Filed: December 19, 2014
    Publication date: April 23, 2015
    Inventors: Heike Prinz, Bjorn Schurad, Thomas Beckert, Kristina Linder
  • Transdermal therapeutic system for administering rivastigmine or derivatives thereof
    Patent number: 8962014
    Abstract: The present invention relates to a transdermal therapeutic system for administering an active substance through the skin, comprising: a) a cover layer, b) a reservoir present on the cover layer, comprising a polymer matrix comprising the active substance, c) an adhesive layer present on the reservoir comprising a contact adhesive, and d) a removable layer present on the adhesive layer, the active substance being rivastigmine, a physiologically compatible salt, hydrate, solvate or derivative thereof, characterized in that the polymer matrix of the reservoir comprises neither hydroxyl groups nor carboxyl groups.
    Type: Grant
    Filed: December 14, 2010
    Date of Patent: February 24, 2015
    Assignee: Acino AG
    Inventors: Heike Prinz, Björn Schurad, Thomas Beckert, Kristina Linder
  • Transdermal Therapeutic System for Administering an Active Substance
    Publication number: 20140323996
    Abstract: The present invention relates to a transdermal therapeutic system for administering an active substance through the skin, said system being suitable for an application period of at least three days, comprising the layers arranged in the following order with respect to each other: a) a cover layer, b) an active substance layer comprising a polymer matrix containing the active substance, c) an adhesive layer comprising a contact adhesive, which consists of a mixture of one or more polyisobutylenes and one or more polybutenes, and d) a pull-off layer.
    Type: Application
    Filed: December 14, 2011
    Publication date: October 30, 2014
    Applicant: ACINO AG
    Inventors: Britta Langer, Björn Schurad, Heike Prinz
  • Transdermal Therapeutic System For Administering Rivastigmine Or Derivatives Thereof
    Publication number: 20130261571
    Abstract: The present invention relates to a transdermal therapeutic system for administering an active substance through the skin, comprising: a) a cover layer, b) a reservoir present on the cover layer, comprising a polymer matrix comprising the active substance, c) an adhesive layer present on the reservoir comprising a contact adhesive, and d) a removable layer present on the adhesive layer, the active substance being rivastigmine, a physiologically compatible salt, hydrate, solvate or derivative thereof, characterized in that the polymer matrix of the reservoir comprises neither hydroxyl groups nor carboxyl groups.
    Type: Application
    Filed: December 14, 2010
    Publication date: October 3, 2013
    Applicant: Acino AG
    Inventors: Heike Prinz, Bjorn Schurad